Tools
Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis in Adults 70 and Younger (MIPSS70+ v2.0)
Predicts survival in patients under the age of 70 with primary myelofibrosis (MF)
Predicts survival in patients under the age of 70 with primary myelofibrosis (MF)